Activating mutations of BRAF have been found in colorectal, ovarian [3], thyroid [38], and lung cancers [39] as well as in cholangiocarcinoma [40], but the highest rate of BRAF mutations (overall, about half of cases) have been observed in melanoma [41]. This evidence concerns the gene BRAF and melanoma.